Skip to main content
. 2020 Apr 18;52(2):234–239. [Article in Chinese] doi: 10.19723/j.issn.1671-167X.2020.02.007

1.

不同病理分级的前列腺癌人群基本资料和血清检测结果

Basic data for PCa patients with different Gleason score

Items Gleason score≥7(n=278) Gleason score<7(n=44) t/U P
tPSA, total prostate-specific antigen; fPSA, free prostate-specific antigen; f/t, fPSA/tPSA; p2PSA, isoform [-2] proprostate- specific antigen; %p2PSA, p2PSA/(fPSA×1 000)×100; PHI, prostate health index.
Age/years, x±s 67.5±7.1 67.8±7.9 0.238 >0.05
tPSA /(μg/L), M(Min, Max) 13.35 (0.03, 699.5) 8.11 (0.67, 57.33) 2.950 <0.01
fPSA/(μg/L), M(Min, Max) 1.29 (0.01, 47.84) 1.06 (0.26, 6.10) 0.714 >0.05
f/t, M(Min, Max) 0.10 (0.03, 0.67) 0.17(0.04, 0.42) 3.824 <0.01
p2PSA/(ng/L), M(Min, Max) 30.22 (0.25, 10254.36) 18.33 (3.94, 197.42) 3.516 <0.01
%p2PSA, M(Min, Max) 2.50 (0.08, 24.32) 1.27 (0.34, 6.04) 5.346 <0.01
PHI, M(Min, Max) 91.81 (0.01, 3037.97) 35.44 (8.95, 332.87) 5.038 <0.01